• 1. Oxine based unsymmetrical (O?, N, S/Se) pincer ligands and their palladium(ii) complexes: synthesis, structural aspects and applications as a catalyst in amine and copper-free Sonogashira coupling
  Satyendra Kumar,Fariha Saleem,Manish Kumar Mishra,Ajai K. Singh New J. Chem. 2017 41 2745
• 2. Comparative studies on OLED performances of chloro and fluoro substituted Zn(ii) 8-hydroxyquinolinates
  Yanping Huo,Jiguo Lu,Tianhua Lu,Xiaoming Fang,Xinhua Ouyang,Li Zhang,Guozan Yuan New J. Chem. 2015 39 333
• 3. Controllable supramolecular structures and luminescent properties of unique trimeric Zn(ii) 8-hydroxyquinolinates tuned by functional substituents
  Guozan Yuan,Yanping Huo,Xiaoli Nie,Hong Jiang,Bin Liu,Xiaoming Fang,Fenghua Zhao Dalton Trans. 2013 42 2921
• 4. The very rapid zinc(II)- and copper(II)-promoted hydrolysis of 8-acetoxyquinoline-2-carboxylic acid. A model for the rate of catalysis by carboxypeptidase A
  Robert W. Hay,Charles R. Clark J. Chem. Soc. Dalton Trans. 1977 1993
• 5. Effect of poly(diallyldimethylammonium chloride) and of poly(ethyleneimine) on the esterolysis of 8-acetoxyquinoline
  Antonio Arcelli,Carlo Concilio J. Chem. Soc. Perkin Trans. 2 1983 1327

Quinolin-8-yl acetate (CAS No. 2598-29-0): A Comprehensive Overview

Quinolin-8-yl acetate, chemically designated as 8-acetoxyquinoline, is a significant compound in the realm of pharmaceutical and chemical research. With a CAS number 2598-29-0, this heterocyclic organic compound has garnered considerable attention due to its versatile applications and structural properties. This detailed introduction aims to provide an in-depth exploration of Quinolin-8-yl acetate, its chemical characteristics, synthetic pathways, and its emerging role in modern medicinal chemistry.

The molecular structure of Quinolin-8-yl acetate consists of a quinoline core substituted with an acetoxy group at the 8-position. This configuration imparts unique reactivity and functionalization possibilities, making it a valuable scaffold in drug discovery. The quinoline moiety is well-known for its presence in numerous bioactive molecules, including antibiotics, antimalarials, and anticancer agents. The acetoxy group further enhances its utility by providing a site for further chemical modifications, enabling the synthesis of more complex derivatives.

In recent years, Quinolin-8-yl acetate has been extensively studied for its potential pharmacological properties. One of the most compelling areas of research involves its application as an intermediate in the synthesis of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is often associated with various diseases, particularly cancer. By leveraging the structural features of Quinolin-8-yl acetate, researchers have developed novel compounds that exhibit potent inhibitory effects on specific kinases, demonstrating promise in preclinical studies.

Moreover, the compound has shown promise in the development of antimicrobial agents. The quinoline scaffold is known for its ability to interact with bacterial DNA and RNA, disrupting essential cellular processes. Studies have indicated that derivatives of Quinolin-8-yl acetate exhibit significant activity against Gram-negative and Gram-positive bacteria, as well as certain fungi. This makes it a valuable candidate for further exploration in combating antibiotic-resistant strains.

The synthesis of Quinolin-8-yl acetate can be achieved through several routes, each offering distinct advantages depending on the desired scale and purity requirements. One common method involves the reaction of 8-hydroxyquinoline with acetic anhydride under acidic conditions. This approach is favored for its simplicity and high yield, making it suitable for industrial-scale production. Alternatively, palladium-catalyzed cross-coupling reactions have been explored as a means to introduce the acetoxy group more selectively, allowing for greater control over regioisomer formation.

Recent advancements in synthetic methodologies have also enabled the preparation of chiral derivatives of Quinolin-8-yl acetate. Chirality plays a critical role in the pharmacological activity of many drugs, as enantiomers can exhibit vastly different biological effects. By employing asymmetric synthesis techniques, researchers have been able to produce enantiomerically pure forms of this compound, opening up new avenues for drug development. These advances highlight the importance of Quinolin-8-yl acetate as a building block in modern medicinal chemistry.

The analytical characterization of Quinolin-8-yl acetate is another area where significant progress has been made. High-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry (MS) are routinely employed to confirm the identity and purity of the compound. These techniques provide detailed insights into its molecular structure and interactions with other molecules, which are essential for understanding its biological activity.

One particularly intriguing aspect of Quinolin-8-yl acetate is its potential role in photodynamic therapy (PDT). PDT involves the use of photosensitizers that generate reactive oxygen species upon exposure to light, leading to cell death. Studies have demonstrated that certain derivatives of quinoline can act as photosensitizers when incorporated into drug molecules. The acetoxy group in Quinolin-8-yl acetate provides a platform for further functionalization, allowing researchers to design photosensitizers with optimized properties such as improved solubility and tissue penetration.

The future prospects for Quinolin-8-yl acetate are vast and multifaceted. As our understanding of disease mechanisms continues to evolve, so does our ability to design targeted therapies. The structural versatility of this compound makes it an ideal candidate for exploring new therapeutic modalities across various therapeutic areas. Whether it is through kinase inhibition, antimicrobial applications, or photodynamic therapy, Quinolin-8-yl acetate stands at the forefront of innovation in pharmaceutical research.

In conclusion,Quinolin-8-yl acetate (CAS No. 2598-29-0) is a remarkable compound with far-reaching implications in medicinal chemistry and drug development. Its unique structural features and reactivity make it a valuable tool for synthesizing novel bioactive molecules. As research progresses, we can anticipate even more exciting applications emerging from this versatile scaffold.

• 63333-80-2(Acetic acid, (8-quinolinyloxy)-, methyl ester)
• 86137-76-0(Octadecanoic acid, 8-quinolinyl ester)
• 5568-49-0(quinolin-8-yl chloroacetate)
• 5594-91-2(1H-indol-5-yl acetate)
• 608-08-2(3-Indolyl Acetate)
• 34493-87-3(Quinolin-8-yl acrylate)
• 27452-38-6(Quinolinium,8-(acetyloxy)-1-methyl-)
• 5526-13-6(7-Acetoxyindole)
• 479252-70-5(Quinolin-5-yl acetate)
• 24306-33-0(Quinolin-6-yl acetate)